
After IMMA’s ‘Breakthrough’ Convention, It’s Time To Break Up
Seven things TINA.org learned from attending MLM’s three-day event virtually.
Bubak et al v. GOLO, LLC
21-cv-492, E.D. Cal.
(March 2021)
GOLO’s Release Supplement
Implying that the supplement mitigates and prevents diabetes, heart disease, and Alzheimer’s disease by claiming that it is “the Natural Solution to Insulin Resistance”
Misleadingly marketing the supplement as “Clinically Proven” when the company relies on pilot studies that it paid for and that have not been peer reviewed or published in legitimate scientific publications
Pending
Seven things TINA.org learned from attending MLM’s three-day event virtually.
Steve Toloken , Plastic News
Company misleadingly markets lozenges as an effective nasal decongestant, according to lawsuit.
These claims make our stomach growl.
Allyson Chiu, The Washington Post